Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in Myanmar
Myanmar: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology was 1.3% in 2024. ▼ Falling
Latest (2024)
1.3%
Change on year
up 8.3%
World rank
24th
of 215 countries
All-time high
1.7%
in 2016
All-time low
0.8%
in 2019
Years of data
10
2015–2024
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in Myanmar, 2015–2024
Source: United Nations Statistics Division, SDG Global Database.
Analysis
Myanmar recorded 1.3% for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in 2024.
The figure is up 8.3% on the previous year and down 18.8% over ten years.
Over the whole period, prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Myanmar peaked at 1.7% in 2016 and was at its lowest, 0.8%, in 2019.
Myanmar ranks 24th of 215 countries on this measure, in the top quarter.
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in Myanmar, year by year
| Year | Value | Change |
|---|---|---|
| 2015 | 1.6% | — |
| 2016 | 1.7% | +6.2% |
| 2017 | 1.3% | -23.5% |
| 2018 | 1.0% | -23.1% |
| 2019 | 0.8% | -20.0% |
| 2020 | 0.8% | +0.0% |
| 2021 | 1.0% | +25.0% |
| 2022 | 1.1% | +10.0% |
| 2023 | 1.2% | +9.1% |
| 2024 | 1.3% | +8.3% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 1.3% | 0.8% | 1.7% | 5 |
| 2020s | 1.1% | 0.8% | 1.3% | 5 |
Countries ranked near Myanmar
More development goals data for Myanmar
- Red List Index 0.8567 (2025)
- Number of refugees per 100,000 population, by country of origin 2,606 (2025)
- Manufacturing value added per capita 334.82 (2025)
- Number of transboundary breeds 22 (2025)
- Number of transboundary breeds (not extinct) 22 (2025)
- Number of transboundary breeds with unknown risk status 22 (2025)
- Number of local breeds with unknown risk status 19 (2025)
- Number of local breeds (not extinct) 19 (2025)
- Number of local breeds kept in the country 19 (2025)
- Infant deaths 29,371 (2024)
Frequently asked questions
- What is prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Myanmar?
- Prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Myanmar was 1.3% in 2024, according to United Nations Statistics Division, SDG Global Database.
- What is the highest prevalence of hepatitis b surface antigen (hbsag), 2026 methodology recorded in Myanmar?
- The highest recorded value was 1.7% in 2016.
- What is the lowest prevalence of hepatitis b surface antigen (hbsag), 2026 methodology recorded in Myanmar?
- The lowest recorded value was 0.8% in 2019.
- How does Myanmar rank for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Myanmar ranks 24th out of 215 countries with data for 2024.
- Is prevalence of hepatitis b surface antigen (hbsag), 2026 methodology rising or falling in Myanmar?
- Over the last ten years it is down 18.8%. The long-run trend across the full record is falling.
- Where does this Myanmar data come from?
- The figures come from United Nations Statistics Division, SDG Global Database, published as part of Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 10 observations, free to reuse under UN SDG Global Database (open, attribution requested).